An Alu polymorphism intragenic to the TP53 gene

por Futreal, P.A., Barrett, J.C., Wiseman, R.W.
Publicado 1991

Bcl10 is not a target for frequent mutation in human carcinomas

por Lambers, A R, Gumbs, C, Ali, S, Marks, J R, Iglehart, J D, Berchuck, A, Futreal, P A
Publicado 1999

COSMIC 2005

por Forbes, S, Clements, J, Dawson, E, Bamford, S, Webb, T, Dogan, A, Flanagan, A, Teague, J, Wooster, R, Futreal, P A, Stratton, M R
Publicado 2006

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

por Bamford, S, Dawson, E, Forbes, S, Clements, J, Pettett, R, Dogan, A, Flanagan, A, Teague, J, Futreal, P A, Stratton, M R, Wooster, R
Publicado 2004

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition

por Mahoney, C L, Choudhury, B, Davies, H, Edkins, S, Greenman, C, Haaften, G van, Mironenko, T, Santarius, T, Stevens, C, Stratton, M R, Futreal, P A
Publicado 2009

The Catalogue of Somatic Mutations in Cancer (COSMIC)

por Forbes, S.A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J.W., Futreal, P.A., Stratton, M.R.
Publicado 2008

BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

por Lancaster, J. M., Carney, M. E., Gray, J., Myring, J., Gumbs, C., Sampson, J., Wheeler, D., France, E., Wiseman, R., Harper, P., Futreal, P. A.
Publicado 1998

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

por Tonin, P N, Mes-Masson, A M, Futreal, P A, Morgan, K, Mahon, M, Foulkes, W D, Cole, D E, Provencher, D, Ghadirian, P, Narod, S A
Publicado 1998

AutoCSA, an algorithm for high throughput DNA sequence variant detection in cancer genomes

por Dicks, E., Teague, J. W., Stephens, P., Raine, K., Yates, A., Mattocks, C., Tarpey, P., Butler, A., Menzies, A., Richardson, D., Jenkinson, A., Davies, H., Edkins, S., Forbes, S., Gray, K., Greenman, C., Shepherd, R., Stratton, M. R., Futreal, P. A., Wooster, R.
Publicado en Bioinformatics (2007)

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

por Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J.S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., Godfrey, A.L., Rapado, I., Cvejic, A., Rance, R., McGee, C., Ellis, P., Mudie, L.J., Stephens, P.J., McLaren, S., Massie, C.E., Tarpey, P.S., Varela, I., Nik-Zainal, S., Davies, H.R., Shlien, A., Jones, D., Raine, K., Hinton, J., Butler, A.P., Teague, J.W., Baxter, E.J., Score, J., Galli, A., Della Porta, M.G., Travaglino, E., Groves, M., Tauro, S., Munshi, N.C., Anderson, K.C., El-Naggar, A., Fischer, A., Mustonen, V., Warren, A.J., Cross, N.C.P., Green, A.R., Futreal, P.A., Stratton, M.R., Campbell, P.J.
Publicado 2011

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

por Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., Cogdill, A. P., Zhao, L., Hudgens, C. W., Hutchinson, D. S., Manzo, T., de Macedo, M. Petaccia, Cotechini, T., Kumar, T., Chen, W. S., Reddy, S. M., Sloane, R. Szczepaniak, Galloway-Pena, J., Jiang, H., Chen, P. L., Shpall, E. J., Rezvani, K., Alousi, A. M., Chemaly, R. F., Shelburne, S., Vence, L. M., Okhuysen, P. C., Jensen, V. B., Swennes, A. G., McAllister, F., Sanchez, E. Marcelo Riquelme, Zhang, Y., Le Chatelier, E., Zitvogel, L., Pons, N., Austin-Breneman, J. L., Haydu, L. E., Burton, E. M., Gardner, J. M., Sirmans, E., Hu, J., Lazar, A. J., Tsujikawa, T., Diab, A., Tawbi, H., Glitza, I. C., Hwu, W. J., Patel, S. P., Woodman, S. E., Amaria, R. N., Davies, M. A., Gershenwald, J. E., Hwu, P., Lee, J. E., Zhang, J., Coussens, L. M., Cooper, Z. A., Futreal, P. A., Daniel, C. R., Ajami, N. J., Petrosino, J. F., Tetzlaff, M. T., Sharma, P., Allison, J. P., Jenq, R. R., Wargo, J. A.
Publicado en Science (2017)